Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1,3,5-trimethoxybenzene
1. 4463-03-0
2. 2,4,6-trimethylbenzene-1,3,5-triol
3. Trimethylphloroglucin
4. 2,4,6-trimethyl-1,3,5-benzenetriol
5. 2,4,6-trimethylphloroglucinol
6. Trimethyl Phloroglucino
7. Schembl320898
8. Trimethylbenzene-1,3,5-triol
9. Dtxsid80196258
10. Zinc3650253
11. Ft-0675631
12. A936958
Molecular Weight | 168.19 g/mol |
---|---|
Molecular Formula | C9H12O3 |
XLogP3 | 1.9 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 0 |
Exact Mass | 168.078644241 g/mol |
Monoisotopic Mass | 168.078644241 g/mol |
Topological Polar Surface Area | 60.7 Ų |
Heavy Atom Count | 12 |
Formal Charge | 0 |
Complexity | 113 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
Registrant Name : Bansen Co., Ltd.
Registration Date : 2021-12-03
Registration Number : 20211203-209-J-1169
Manufacturer Name : Patheon Austria GmbH & Co KG
Manufacturer Address : St. Peter Strasse 25, 4020 Linz Austria
About the Company : Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities ar...
About the Company : Jiangsu Lianhuan Pharmaceutical Co., Ltd. was founded in 2000. It is a state-controlled competitive listed company. Its predecessor was Yangzhou Pharmaceutical Factory, which was e...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
Reply
22 Jul 2024
Reply
01 Jul 2024
Reply
20 Mar 2023
Reply
28 Oct 2021
Reply
31 May 2021
Reply
30 Apr 2021
Reply
02 Mar 2020
Reply
20 Nov 2019
ABOUT THIS PAGE
A Trimethyl Phloroglucinol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trimethyl Phloroglucinol, including repackagers and relabelers. The FDA regulates Trimethyl Phloroglucinol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trimethyl Phloroglucinol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Trimethyl Phloroglucinol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Trimethyl Phloroglucinol supplier is an individual or a company that provides Trimethyl Phloroglucinol active pharmaceutical ingredient (API) or Trimethyl Phloroglucinol finished formulations upon request. The Trimethyl Phloroglucinol suppliers may include Trimethyl Phloroglucinol API manufacturers, exporters, distributors and traders.
click here to find a list of Trimethyl Phloroglucinol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Trimethyl Phloroglucinol Drug Master File in Korea (Trimethyl Phloroglucinol KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Trimethyl Phloroglucinol. The MFDS reviews the Trimethyl Phloroglucinol KDMF as part of the drug registration process and uses the information provided in the Trimethyl Phloroglucinol KDMF to evaluate the safety and efficacy of the drug.
After submitting a Trimethyl Phloroglucinol KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Trimethyl Phloroglucinol API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Trimethyl Phloroglucinol suppliers with KDMF on PharmaCompass.
Trimethyl Phloroglucinol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Trimethyl Phloroglucinol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Trimethyl Phloroglucinol GMP manufacturer or Trimethyl Phloroglucinol GMP API supplier for your needs.
A Trimethyl Phloroglucinol CoA (Certificate of Analysis) is a formal document that attests to Trimethyl Phloroglucinol's compliance with Trimethyl Phloroglucinol specifications and serves as a tool for batch-level quality control.
Trimethyl Phloroglucinol CoA mostly includes findings from lab analyses of a specific batch. For each Trimethyl Phloroglucinol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Trimethyl Phloroglucinol may be tested according to a variety of international standards, such as European Pharmacopoeia (Trimethyl Phloroglucinol EP), Trimethyl Phloroglucinol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Trimethyl Phloroglucinol USP).
LOOKING FOR A SUPPLIER?